Pharmaceutical Packaging
Stop TB
Pharmaceutical Packaging
Stop TB
previous next

The Human Impact of Counterfeit and Substandard Medicines

Human impact of substandard medicines

To help illustrate the true threat of counterfeit and substandard medicines, and demonstrate why USP and so many other organizations are working to improve drug quality, we offer this first-hand story about two near-fatal encounters with bad drugs.

Share

Dietary Supplements – International Regulators Respond to a New and Growing Industry

Regulators respond to a changing dietary supplement industry

Before the Dietary Supplement Health and Education Act (DSHEA) defined dietary supplements as a sub-set of foods, questions about how they would be regulated created heated discussion in the US market.

Share

USP and Dietary Supplements ... A Return to Our Roots

The history and dramatic growth of the dietary supplement industry

Since its beginnings, the United States Pharmacopeial Convention (USP) has been concerned with setting quality standards for botanicals and minerals. On the eve of the 20th anniversary of the Dietary Supplement Health and Education Act (DSHEA), Dr. Srini Srinivasan, Executive Vice President, Special Assignments and Chief Science Officer at USP, reflects on the dramatic growth of the dietary supplement industry, USP’s changing role as a standards setting body and the impact of DSHEA.

Share

Pages

Related Stories

USP Excipient Monographs & Standards
USP Excipient Monographs & Standards
Characterization of Biologics: USP Standards
Counterfeit drugs are putting the whole world at risk
Medicine Quality Assurance: USP's Technical Review Program